Seòmar agus comataidhean

There have been no official complaints logged regarding the overall condition of the A90 in the last five years. However, there has been a total of 171 individual complaints with resulting reports:

Pool cars are allocated to specific areas who have a business need for their use which cannot be met by public transport or other sustainable methods of travel. This includes conducting legislative and compliance inspections, animal and horticulture inspections, delivery of equipment and the transportation of Ministers.

The Kingston Bridge Complex in Glasgow receives a rigorous programme of regular inspections. The output from these inspections is used to inform current and future maintenance programmes. Any defects identified from these inspections are prioritised and taken forward for future repair, if necessary.

The concrete spalling reported on 14 January 2025, immediately above Paisley Road, was related to an historic concrete repair, which broke loose after the recent period of cold weather. There are other historic repairs within the complex and, to address this issue and to ensure public safety, Transport Scotland’s Operating Company, Amey, has instigated further close visual special inspections to identify and remove any loose concrete at these historic repairs. These inspections are underway and will continue over the next few weeks.

We do not hold this information.

The Scottish Government has set out its commitment to giving people information about independence. A range of civil servants across the Scottish Government provide input to developing and communicating this information.

The largest proportion of funding has been awarded to projects that improve services for all or more than one neurological condition, including services for carers. Direct investment was also made to projects for the following specific conditions:

• Acquired Brain Injury
• Cerebral Palsy
• Epilepsy
• Functional Neurological Disorder (FND)
• Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
• Migraine
• Multiple Sclerosis (MS)
• Parkinson’s Disease
• Progressive Supranuclear Palsy (PSP)
• Psychogenic Non-Epileptic Seizures
• Spina bifida/ hydrocephalus

A full list of projects funded through the Neurological Framework can be found here.

Funding allocation to research by Scottish Universities in 2024-25 is £54,787. The National Mission is further supported by research undertaken at national and local levels by national boards such as Public Health Scotland and Health Improvement Scotland and third sector partners.

In October 2024, Chief Scientist Office (CSO) announced Phase 2 of the Reducing Drug Deaths Innovation Challenge. This £5 million partnership between CSO and UK Government Office for Life Sciences funds 7 innovation projects to address the rising issue of drug-related deaths. CSO contribute £500,000 to this partnership.

In addition, we provided funding of £52,500 to the University of Edinburgh to host the Drugs Research Network Scotland to deliver knowledge exchange activities through an annual conference and regular webinars and to monitor ongoing research activities.

Priorities for the Scottish Government are:

• national implementation of the Scottish Epilepsy Register,
• further adoption of successful approaches to improving services through the neurological conditions network,
• continued improvements in provision of ‘social support’ and psychological services for people with neurological conditions,
• continued development and adoption of condition specific care pathways,
• continued development and adoption of approaches to workforce planning and training for nursing, pharmacy, neuropsychology allied health professionals, and neurophysiology.

This work will be considered as part of the development of the Long Term Conditions Strategy due to be published later this year. Any required funding will be considered during the 2025-26 budget deliberations.

The Scottish Government’s decision-making for the flu vaccination programmes is guided by the expert clinical advice of the Joint Committee on Vaccination and Immunisation (JCVI). The JCVI typically advises flu vaccination for all those aged 65 years and over, and all those aged 6 months to 64 years in a clinical at risk group.

Scotland expanded its flu programme as part of our response to the COVID-19 pandemic, to help reduce pressure on the NHS in unprecedented times. In winter 2020-21 we expanded it to those aged 55 years and over and then to those aged 50 years and over in 2021-22, 2022-23 and 2023-24.

As we move beyond the COVID-19 pandemic, from winter 2024-25 we have reverted to the standard JCVI-advised groups and those aged 50-64 years are no longer included in the national flu programme. This is in line with the approach taken by other UK nations. The only nation currently offering the flu vaccine to the 50-64 years group is Northern Ireland, who announced their decision to expand their programme on 15 January 2025. They took the same approach in January 2024. The position for winter 2024-25 in England and Wales is currently the same as in Scotland.

I wrote to MSPs on 12 September 2024 to outline the changes to eligibility for flu and COVID-19 vaccination this winter, and the reason for those changes.

We have not received data or clinical advice to support any expansion of the programme to those aged 50-64 years, or other groups. Over the festive period, flu cases and hospital admissions due to flu peaked above typical levels for wintertime. These are now showing notable signs of decline in the latest two weeks ending 5 and 12 January 2025. Flu-related hospital admissions in Scotland decreased by 46.6% from 1,077 in week ending 5 January to 575 in week ending 12 January. Laboratory-confirmed flu case numbers have declined for a second week, by 40.6% from 1,906 in week ending 5 January to 1,133 in week ending 12 January. PHS surveillance stats can be found here - PHS Vaccination Surveillance.

Within the Scottish Government, funding of Health and Care Research comes under the remit of the Chief Scientist Office (CSO).

CSO funds research projects via its Translational Clinical Studies (TCS) Committee and the Health Improvement, Protection and Services Research (HIPS) Committee

https://www.cso.scot.nhs.uk/grant-funding/response-mode-funding-schemes/

CSO funds capacity building research via its Fellowship Funding programmes

https://www.cso.scot.nhs.uk/fellowship-funding/

Research funding is not allocated to any particular condition and CSO funds research across the clinical spectrum. All applications go through a process of independent expert review to allow funding decisions to be made. Applications on Brain Tumours are welcomed and CSO's role is well known across the Health and Care research community in Scotland

In 2023-24 the following funding was awarded specifically for research in Brain Cancer

TCS/23/18 - Assessment of Brain Tumours with Dynamic T2* and Lactate MR under Oxygen Challenge to Evaluate Aerobic and Anaerobic Metabolic Status of Gliomas

£299,918

Tessa Jowell Fellowship in Neuro-oncology

£44,237

In addition, CSO provides infrastructure funding to support the delivery of clinical studies in the NHS in Scotland. In 2023-24 the cancer-specific component of this infrastructure funding was £1,112,434. This figure includes funding for the NHS Research Scotland Cancer Research Network and the CSO component of funding for the Experimental Cancer Medicine Centres in Edinburgh and Glasgow (co-funded 50:50 with Cancer Research UK). The purpose of this funding is to support the delivery of early and later phase cancer clinical studies, including in Brain Tumours.